Trial Profile
Ambulatory 24-Hour Cardiac Oxygen Consumption and Blood Pressure-Heart Rate Variability: Effects of Nebivolol and Valsartan Alone and in Combination
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Nebivolol/valsartan (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.